Parag Mallick - 08 May 2025 Form 4 Insider Report for Nautilus Biotechnology, Inc. (NAUT)

Reporting relationship: Chief Scientist, Director, 10%+ Owner
Issuer ticker: NAUT
Reported as of: 08 May 2025
Net transaction value: +$9,885
SEC form: 4
Accepted by SEC: 12 May 2025, 19:19:33 UTC
Prior SEC filing: 04 Mar 2025
Next SEC filing: 04 Mar 2026
Source filing: View source filing
Reporting owner signature: /a/ Anna Mowry, as Attorny-in-Fact

Key filing fact

Parag Mallick filed Form 4 for Nautilus Biotechnology, Inc. (NAUT) on 12 May 2025.

Key facts

This page summarizes Parag Mallick's Form 4 filing for Nautilus Biotechnology, Inc. (NAUT).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 12 May 2025, 19:19.

Change

Previous filing in this sequence was filed on 04 Mar 2025.
Current net transaction value: +$9,885.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001857948 Primary reporting owner

Mallick Parag

Relationship: Chief Scientist, Director, 10%+ Owner
Address: C/O NAUTILUS BIOTECHNOLOGY, INC., 2701 EASTLAKE AVENUE EAST, SEATTLE
Signature: /a/ Anna Mowry, as Attorny-in-Fact
Signature date: 12 May 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NAUT transaction

Common Stock

Purchase

Transaction value: $8,788
Shares: +12,000
Change %: +0.06%
Price: $0.7323
Shares after: 20,491,892
Date: 08 May 2025
Ownership: Direct
Footnotes: F1

NAUT transaction

Common Stock

Purchase

Transaction value: $1,098
Shares: +1,500
Change %: +0.01%
Price: $0.7317
Shares after: 20,493,392
Date: 12 May 2025
Ownership: Direct
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents the weighted average share price of an aggregate total of 12,000 shares purchased in the price range of $0.7058 to $0.7520 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

Footnote F2

Represents the weighted average share price of an aggregate total of 1,500 shares purchased in the price range of $0.7229 to $0.7334 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.